MACROmol Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

MACROmol General Information

Description

Developer of a polymeric platform intended to treat tuberculosis. The company's polymeric platform offers a multi-medicine system for nanomedicine innovation to maximize the clinical impact of therapeutics, enabling patients to have fewer drug regimens with improved results.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Cambridge
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MACROmol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Apr-2015 Completed Startup
To view MACROmol’s complete valuation and funding history, request access »

MACROmol Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelerate Cambridge Accelerator/Incubator 000 0000 000000 0
To view MACROmol’s complete investors history, request access »